SCOPUS 정보 검색 플랫폼

Volumn 33, Issue 4, 2010, Pages 728-729

Review of adverse events associated with false glucose readings measured by GDH-PQQ-based glucose test strips in the presence of interfering sugars

(4) Frias, Juan P a Lim, Christine G a Ellison, John M a Montandon, Carol M a

a LifeScan (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABATACEPT; EXTRANEAL; GALACTOSE; GLOBULIN; GLUCOSE DEHYDROGENASE; HEPATITIS B ANTIBODY; ICODEXTRIN; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; INSULIN; MALTODEXTRIN; MALTOSE; PYRROLOQUINOLINEQUINONE; RHESUS D ANTIBODY; TOSITUMOMAB; TOSITUMOMAB I 131; XYLOSE;

ARTICLE; BLOOD GLUCOSE METER; BLOOD GLUCOSE MONITORING; DEATH; DIAGNOSTIC ACCURACY; DIALYSATE; FALSE POSITIVE RESULT; GALACTOSEMIA; HOSPITAL PATIENT; HUMAN; HYPOGLYCEMIA; INSULIN TREATMENT; MAJOR CLINICAL STUDY; OUTPATIENT; SAFETY; SENSITIVITY AND SPECIFICITY; TEST STRIP;

BLOOD GLUCOSE; BLOOD GLUCOSE SELF-MONITORING; FALSE POSITIVE REACTIONS; HUMANS; REAGENT STRIPS;

EID: 77953072186 PISSN: 01495992 EISSN: 19355548 Source Type: Journal
DOI: 10.2337/dc09-1822 Document Type: Article

Times cited : (54)

References (7)

1
- 80054729630
- Available from Accessed 13 August 2009
- Food and Drug Administration: FDA public health notification: potentially fatal errors with GDH-P glucose monitoring technology [article online], 2009. Available from http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/ PublicHealthNotifications/ucm176992.htm. Accessed 13 August 2009
- (2009) FDA Public Health Notification: Potentially Fatal Errors with GDH-P Glucose Monitoring Technology [Article Online]

2
- 69249212529
- Frequency of hypoglycemia and its significance in chronic kidney disease
- Moen M, Zhan M, Hsu V, Walker L, Einhorn L, Seliger S, Fink J. Frequency of hypoglycemia and its significance in chronic kidney disease. Clin J Am Soc Nephrol 2009;4:1121-1127
- (2009) Clin J Am Soc Nephrol , vol.4 , pp. 1121-1127
- Moen, M.¹ Zhan, M.² Hsu, V.³ Walker, L.⁴ Einhorn, L.⁵ Seliger, S.⁶ Fink, J.⁷

3
- 54749099644
- Unlabeled uses of intravenous immune globulin
- Leong H, Stachnik J, Bonk ME, Matuszewski KA. Unlabeled uses of intravenous immune globulin. Am J Health-Sys Pharm 2008;65:1815-1824
- (2008) Am J Health-Sys Pharm , vol.65 , pp. 1815-1824
- Leong, H.¹ Stachnik, J.² Bonk, M.E.³ Matuszewski, K.A.⁴

4
- 33646249914
- Current usage of intravenous immune globulin and the rationale behind it: Massachusetts General Hospital data and a review of the literature
- Darabi K, Abdelllll-Wahab O, Dzik W. Current usage of intravenous immune globulin and the rationale behind it: Massachusetts General Hospital data and a review of the literature. Transfusion 2006;46:741-753
- (2006) Transfusion , vol.46 , pp. 741-753
- Darabi, K.¹ Abdelllll-Wahab, O.² Dzik, W.³

5
- 0032417803
- Limitations and strengths of spontaneous report data
- Goldman SA. Limitations and strengths of spontaneous report data. Clin Thera 1998;20(Suppl. C):40-44
- (1998) Clin Thera , vol.20 , Issue.SUPPL. C , pp. 40-44
- Goldman, S.A.¹

6
- 0034748578
- How the US Food and Drug Administration defines and detects adverse drug events
- Trontell AE. How the US Food and Drug Administration defines and detects adverse drug events. Curr Ther Res Clin Exp 2001;62:641-649
- (2001) Curr Ther Res Clin Exp , vol.62 , pp. 641-649
- Trontell, A.E.¹

7
- 22144491929
- Trocar-associated injuries and fatalities An analysis of 1399 reports to the FDA
- Fuller J, Ashar, Carey-Corrado J. Trocar-associated injuries and fatalities: An analysis of 1399 reports to the FDA. J Minim Invasive Gynecol 2005;12:302-307
- (2005) J Minim Invasive Gynecol , vol.12 , pp. 302-307
- Fuller, J.¹ Ashar² Carey-Corrado, J.³

* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.